Dovato Vs Biktarvy
Dovato Vs Biktarvy. Dovato and Biktarvy are two of the major anti-HIV medicines used today. These drugs function by lessening the impact of the virus on the body. Let us learn the difference between these drugs, especially their definitions, uses, dosages, and side effects.
Dovato is a mixture of dolutegravir and lamivudine. Dolutegravir is part of a class of drugs known as HIV integrase inhibitors. Meanwhile, lamivudine is a nucleoside reverse transcriptase inhibitor. The mixture of these antiviral drugs prevents the infection from advancing to AIDS.
On the other hand, Biktarvy is a composition of bictegravir, emtricitabine, and tenofovir alafenamide. The mixture of these three drugs prevents the infection from spreading and growing its number within the body. Bictegravir is an integrase inhibitor, while emtricitabine and tenofovir alafenamide are nucleotide reverse transcriptase inhibitors (NRTIs).
Drug interaction is possible with Dovato treatment. Here is the list of drugs that may interact with this medicine.
- John’s wort
- Iron supplements
Here is also the list of drugs that can interact with Biktarvy treatment.
- John’s wort
In terms of dosage, both Dovato and Biktarvy share similar consumption frequencies. For both the drugs, doctors prescribe one tablet per day. Consume any of these medicines with or without food. However, doctors recommend taking it with food to avoid episodes of stomachaches.
Most of the antiviral drugs used under antiretroviral therapy have similar side effects. Some of the most common adverse reactions in taking Dovato and Biktarvy are:
- Mild to severe headache
- Irregular heartbeat
- Flu-like symptoms